Janney Montgomery Scott
NGNE icon

Janney Montgomery Scott’s Neurogene NGNE Stock Holding History

Janney Montgomery Scott’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,000
Closed -$14K – 2693
2023
Q1 		$14K Hold
1,000
– – ﹤0.01% 2435
2022
Q4 		$10K Hold
1,000
– – ﹤0.01% 2544
2022
Q3 		$13K Hold
1,000
– – ﹤0.01% 2476
2022
Q2 		$21K Hold
1,000
– – ﹤0.01% 2300
2022
Q1 		$38K Hold
1,000
– – ﹤0.01% 2215
2021
Q4 		$96K Hold
1,000
– – ﹤0.01% 2314
2021
Q3 		$145K Hold
1,000
– – ﹤0.01% 2210
2021
Q2 		$185K Hold
1,000
– – ﹤0.01% 2148
2021
Q1 		$246K Buy
1,000
+500
+100% +$128K ﹤0.01% 1961
2020
Q4 		$141K Buy
+500
New +$122K ﹤0.01% 2151

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janney Montgomery Scott's NGNE Position: Q2 2023 in Review

Janney Montgomery Scott sold out of Neurogene (NGNE) in Q2 2023, closing a stake of 1,000 shares — an estimated $14K sold.

Janney Montgomery Scott first reported a position in NGNE in Q4 2020 and held it in 10 quarters. The position peaked at $246K in Q1 2021. 36 funds tracked by Wall St. Rank hold NGNE as of Q2 2023.

  • Janney Montgomery Scott reported no remaining Neurogene position as of Q2 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 1,000 Neurogene shares in Q2 2023, an estimated $14K.
  • Janney Montgomery Scott first reported a position in Neurogene in Q4 2020 and held it in 10 quarters.
  • Janney Montgomery Scott's Neurogene position peaked at $246K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Neurogene as of Q2 2023.

Based on Janney Montgomery Scott's 13F filing for Q2 2023, filed 26 Jul 2023.